FDA Inspection
Seattle Reproductive Medicine, Inc., P.S.Seattle Reproductive Medicine, Inc., P.S. – FDA Inspection, Feb 28, 2020
Record Details
This FDA Inspection record concerns Seattle Reproductive Medicine, Inc., P.S., with an inspection on February 28, 2020, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- February 28, 2020
- Product Type
- Biologics
View Company Profile
ID · ee6e5e84-45a5-4ea0-8442-7c60c79e7acc
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1121341
- FDA center
- Biologics
- Project area
- Blood and Blood Products
Other FDA inspections of Seattle Reproductive Medicine, Inc., P.S.
5| Date | Classification | Office | Project area |
|---|---|---|---|
| July 2, 2025 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| July 11, 2017 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| January 20, 2015 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| December 10, 2012 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| January 14, 2009 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Seattle Reproductive Medicine, Inc., P.S.
- FDA Inspection 1275096 - 2025-07-02
- FDA Inspection 1019977 - 2017-07-11
- FDA Inspection 910138 - 2015-01-20
- FDA Inspection 810062 - 2012-12-10
- FDA Inspection 558831 - 2009-01-14
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.